Search

Search Constraints

You searched for: Author/Creator Recher, Christian

Search Results

21. Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Issue 8 (10th March 2022)

22. Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient. (20th November 2019)

24. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era. (28th November 2017)

25. Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia. Issue 8 (3rd August 2017)

26. Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML. Issue 2 (15th September 2014)

27. Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML. Issue 2 (15th September 2014)

28. Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies. Issue 12 (1st December 2016)

29. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. Issue 10036 (11th June 2016)

30. Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia. Issue 8 (10th June 2022)